Notes Receivable

9 Months Ended

Sep. 30, 2024

Notes Receivable [Abstract]

Notes receivable

7. Notes receivable

Notes receivable consisted of the following at September 30, 2024 and December 31, 2023: 

	September 30,		December 31,
	2024		2023
Notes receivable	$	-	$	100,000

As mentioned above, the Company provided a loan in the aggregate principal amount of $200,000 to PainScript to cover employee liabilities and general working capital. During the year ended December 31, 2023, $100,000 of this loan was repaid.   On December 15, 2023, the loan was amended to have an interest rate of 20% per annuum, and the remaining balance of $100,000 at December 31, 2023 had a maturity date of $50,000 on March 31, 2024 and $50,000 by September 30, 2024. The loan was secured by a pledge of a majority of the voting capital stock of PainScript held by certain PainScript shareholders. The Company also contributed $100,000 to PainScript in order to cover outstanding liabilities. As of May 1, 2024, the full amount of the loan and interest have been paid in full.